Literature DB >> 23934922

Generation of ferric iron links oxidative stress to α-synuclein oligomer formation.

Johannes Levin1, Tobias Högen, Andreas S Hillmer, Benedikt Bader, Felix Schmidt, Frits Kamp, Hans A Kretzschmar, Kai Bötzel, Armin Giese.   

Abstract

BACKGROUND: Synucleinopathies such as Parkinson's disease are characterized by the deposition of aggregated α-synuclein in affected brain areas. As genes involved in mitochondrial function, mitochondrial toxins, and age-related mitochondrial impairment have been implicated in Parkinson's disease pathogenesis, an increase in reactive oxygen species resulting from mitochondrial dysfunction has been speculated to induce α-synuclein aggregation. In vitro, pore-forming, SDS-resistant α-synuclein oligomers are formed in presence of ferric iron and may represent an important toxic particle species. METHODOLOGY/PRINCIPAL
FINDINGS: We investigated the interplay of reactive oxygen species, antioxidants and iron oxidation state in regard to α-synuclein aggregation using confocal single particle fluorescence spectroscopy, Phenanthroline spectrometry and thiobarbituric acid reactive substances assay. We found that the formation of α-synuclein oligomers in presence of Fe³⁺ is due to a direct interaction. In contrast, oxidizing agents and hydroxyl radicals generated in the Fenton reaction did not directly affect α-synuclein oligomerization. However, reactive oxygen species could enhance aggregation via oxidation of ferrous to ferric iron when iron ions were present.
CONCLUSIONS/SIGNIFICANCE: Our data thus indicate that oxidative stress affects α-synuclein aggregation via oxidation of iron to the ferric state. This provides a new perspective on the role of mitochondrial toxins and mitochondrial dysfunction in the pathogenesis of Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 23934922     DOI: 10.3233/JPD-2011-11040

Source DB:  PubMed          Journal:  J Parkinsons Dis        ISSN: 1877-7171            Impact factor:   5.568


  24 in total

Review 1.  Parkinson's disease and iron.

Authors:  Hideki Mochizuki; Chi-Jing Choong; Kousuke Baba
Journal:  J Neural Transm (Vienna)       Date:  2020-02-05       Impact factor: 3.575

2.  Individual Amino Acid Supplementation Can Improve Energy Metabolism and Decrease ROS Production in Neuronal Cells Overexpressing Alpha-Synuclein.

Authors:  Vedad Delic; Jeddidiah W D Griffin; Sandra Zivkovic; Yumeng Zhang; Tam-Anh Phan; Henry Gong; Dale Chaput; Christian Reynes; Vinh B Dinh; Josean Cruz; Eni Cvitkovic; Devon Placides; Ernide Frederic; Hamed Mirzaei; Stanley M Stevens; Umesh Jinwal; Daniel C Lee; Patrick C Bradshaw
Journal:  Neuromolecular Med       Date:  2017-06-15       Impact factor: 3.843

Review 3.  Alpha-synuclein and iron: two keys unlocking Parkinson's disease.

Authors:  Paul Lingor; Eleonora Carboni; Jan Christoph Koch
Journal:  J Neural Transm (Vienna)       Date:  2017-02-06       Impact factor: 3.575

Review 4.  Neuropathological Mechanisms of β-N-Methylamino-L-Alanine (BMAA) with a Focus on Iron Overload and Ferroptosis.

Authors:  Hamed Kazemi Shariat Panahi; Mona Dehhaghi; Benjamin Heng; Darius J R Lane; Ashley I Bush; Gilles J Guillemin; Vanessa X Tan
Journal:  Neurotox Res       Date:  2022-01-13       Impact factor: 3.911

Review 5.  Oxidative Modification and Its Implications for the Neurodegeneration of Parkinson's Disease.

Authors:  Junjun Zhao; Shuqing Yu; Yan Zheng; Hui Yang; Jianliang Zhang
Journal:  Mol Neurobiol       Date:  2016-02-03       Impact factor: 5.590

Review 6.  Prying into the Prion Hypothesis for Parkinson's Disease.

Authors:  Patrik Brundin; Ronald Melki
Journal:  J Neurosci       Date:  2017-10-11       Impact factor: 6.167

7.  Synergistic influence of phosphorylation and metal ions on tau oligomer formation and coaggregation with α-synuclein at the single molecule level.

Authors:  Georg Nübling; Benedikt Bader; Johannes Levin; Jenna Hildebrandt; Hans Kretzschmar; Armin Giese
Journal:  Mol Neurodegener       Date:  2012-07-23       Impact factor: 14.195

Review 8.  Interaction between Neuromelanin and Alpha-Synuclein in Parkinson's Disease.

Authors:  Shengli Xu; Piu Chan
Journal:  Biomolecules       Date:  2015-06-05

Review 9.  Interaction between pathogenic proteins in neurodegenerative disorders.

Authors:  Kurt A Jellinger
Journal:  J Cell Mol Med       Date:  2012-06       Impact factor: 5.310

10.  Single-channel electrophysiology reveals a distinct and uniform pore complex formed by α-synuclein oligomers in lipid membranes.

Authors:  Felix Schmidt; Johannes Levin; Frits Kamp; Hans Kretzschmar; Armin Giese; Kai Bötzel
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.